SummaryTo define the genetic requirements for pancreatic ductal adenocarcinoma (PDA), we have targeted concomitant endogenous expression of Trp53R172H and KrasG12D to the mouse pancreas, revealing the cooperative development of invasive and widely metastatic carcinoma that recapitulates the human disease. The primary carcinomas and metastases demonstrate a high degree of genomic instability manifested by nonreciprocal translocations without obvious telomere erosion—hallmarks of human carcinomas not typically observed in mice. No mutations were discovered in other cardinal tumor suppressor gene pathways, which, together with previous results, suggests that there are distinct genetic pathways to PDA with different biological behaviors. These ...
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy, and the seventh leading c...
SummaryInherited heterozygous BRCA2 mutations predispose carriers to tissue-specific cancers, but so...
SummaryPancreatic ductal adenocarcinoma (PDA), one of the deadliest human cancers, often involves so...
A human pancreatic cancer progression model from intraepithelial neoplasia to ductal adenocarcinoma ...
Pancreatic ductal adenocarcinoma (PDA) is a deadly disease with few treatment options. There is an u...
The presence of distant metastases is a common finding on diagnosis of pancreatic cancer; however, t...
The presence of distant metastases is a common finding on diagnosis of pancreatic cancer; however, t...
The presence of distant metastases is a common finding on diagnosis of pancreatic cancer; however, t...
TP53 mutation occurs in 50–75% of human pancreatic ductal adenocarcinomas (PDAC) following an initia...
Pancreatic cancer is characterized by nearly universal activating mutations in KRAS. Among other som...
Pancreatic cancer (PC) accumulates multiple genetic mutations, including activating KRAS mutations a...
Although survival has improved in recent years, the prognosis of patients with advanced pancreatic d...
The poor correlation of mutational landscapes with phenotypes limits our understanding of the pathog...
Although survival has improved in recent years, the prognosis of patients with advanced pancreatic d...
Although survival has improved in recent years, the prognosis of patients with advanced pancreatic d...
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy, and the seventh leading c...
SummaryInherited heterozygous BRCA2 mutations predispose carriers to tissue-specific cancers, but so...
SummaryPancreatic ductal adenocarcinoma (PDA), one of the deadliest human cancers, often involves so...
A human pancreatic cancer progression model from intraepithelial neoplasia to ductal adenocarcinoma ...
Pancreatic ductal adenocarcinoma (PDA) is a deadly disease with few treatment options. There is an u...
The presence of distant metastases is a common finding on diagnosis of pancreatic cancer; however, t...
The presence of distant metastases is a common finding on diagnosis of pancreatic cancer; however, t...
The presence of distant metastases is a common finding on diagnosis of pancreatic cancer; however, t...
TP53 mutation occurs in 50–75% of human pancreatic ductal adenocarcinomas (PDAC) following an initia...
Pancreatic cancer is characterized by nearly universal activating mutations in KRAS. Among other som...
Pancreatic cancer (PC) accumulates multiple genetic mutations, including activating KRAS mutations a...
Although survival has improved in recent years, the prognosis of patients with advanced pancreatic d...
The poor correlation of mutational landscapes with phenotypes limits our understanding of the pathog...
Although survival has improved in recent years, the prognosis of patients with advanced pancreatic d...
Although survival has improved in recent years, the prognosis of patients with advanced pancreatic d...
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy, and the seventh leading c...
SummaryInherited heterozygous BRCA2 mutations predispose carriers to tissue-specific cancers, but so...
SummaryPancreatic ductal adenocarcinoma (PDA), one of the deadliest human cancers, often involves so...